1. Activating and inhibitory signaling in mast cells: New opportunities for therapeutic intervention? 
Vanessa L. Ott, PhD, John C. Cambier, PhD 
Journal of Allergy and Clinical Immunology 
Volume 106, Issue 3, Pages (September 2000)
DOI: /mai
Copyright © 2000 Mosby, Inc. Terms and Conditions

2. Fig. 1
Inhibition of FcϵRI signaling pathways by FcγRIIB. DAG, Diacylglycerol; PKC, protein kinase C; IP3, Ins (3,4,5) P3.
Journal of Allergy and Clinical Immunology  , DOI: ( /mai )
Copyright © 2000 Mosby, Inc. Terms and Conditions

3. Fig. 2
ITIM-containing inhibitory receptors expressed in mast cells. SHPS-1, src homology 2 domain–containing phosphatase substrate 1; BIT , brain Ig-like molecules with tyrosine-based activation motifs; KLRG1, killer cell lectin-like receptor G1.
Journal of Allergy and Clinical Immunology  , DOI: ( /mai )
Copyright © 2000 Mosby, Inc. Terms and Conditions